共 50 条
- [41] Small Dense Low-Density Lipoprotein Cholesterol Predicts Atherosclerotic Cardiovascular Disease in the Copenhagen General Population StudyJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (22) : 2873 - 2875Balling, MieNordestgaard, Borge G.Langsted, AnneVarbo, AnetteKamstrup, Pia R.Afzal, Shoaib
- [42] Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart studyJOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):Driessen, Maurice T.Cohen, Joshua M.Patterson-Lomba, OscarThompson, Stephen F.Seminerio, MichaelCarr, KarenTotev, Todor, ISun, RochelleYim, EricaMu, FanAyyagari, Rajeev
- [43] Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart studyThe Journal of Headache and Pain, 2022, 23Maurice T. DriessenJoshua M. CohenOscar Patterson-LombaStephen F. ThompsonMichael SeminerioKaren CarrTodor I. TotevRochelle SunErica YimFan MuRajeev Ayyagari
- [44] RELATIONSHIP BETWEEN PERCENTAGE REDUCTION IN LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND MAJOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AMONG PATIENTS TREATED WITH STATINS plus /- ALIROCUMAB OR EZETIMIBE IN THE PHASE 3 ODYSSEY TRIALSJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2082 - 2082Ray, KausikGinsberg, HenryDavidson, MichaelPordy, RobertBessac, LaurenceMinini, PascalEckel, RobertCannon, Christopher
- [45] MULTIMORBIDITY AND ITS ASSOCIATIONS WITH ADVERSE CARDIOVASCULAR EVENTS AND HEALTHCARE COSTS AMONG PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A REAL-WORLD EVIDENCE STUDYVALUE IN HEALTH, 2024, 27 (06) : S181 - S181Dai, D.Fernandes, J.Sun, X.Lupton, L.Berk, A.
- [46] REAL-WORLD STUDY OF TREATMENT INTENSIFICATION OF STATINS IN PATIENTS WITH UNCONTROLLED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)VALUE IN HEALTH, 2019, 22 : S135 - S135Vadhariya, A.Wei, W.Sharma, M.Johnson, M. L.
- [47] REAL-WORLD CHARACTERISTICS AND READMISSIONS AMONG PATIENTS UNDERGOING ABLATION FOR VENTRICULAR TACHYCARDIA: A RETROSPECTIVE DATABASE ANALYSIS OF COMMERCIALLY INSURED PATIENTS IN THE UNITED STATESVALUE IN HEALTH, 2019, 22 : S131 - S131Boo, L.Kalsekar, IZhang, S.Khanna, R.
- [48] Ezetimibe Use and LDL-C Goal Achievement: A Retrospective Database Analysis of Patients with Clinical Atherosclerotic Cardiovascular Disease or Probable Heterozygous Familial HypercholesterolemiaJOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (12): : 1270 - +Menzin, JosephAggarwal, JyotiBoatman, BrianYu, JeffreyStern, KevinHarrison, David J.Patel, Jeetvan G.
- [49] Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reductionPLOS ONE, 2018, 13 (10):Woo, YeongminShin, Jeong-sooShim, Chi-YoungKim, Jung-SunKim, Byeong-KeukPark, SunghaChang, Hyuk-JaeHong, Geu-RuKo, Young-GukKang, Seok-MinChoi, DonghoonHa, Jong-WonHong, Myeong-KiJang, YangsooLee, Sang-Hak
- [50] Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from GermanyATHEROSCLEROSIS, 2018, 268 : 99 - 107Maerz, WinfriedDippel, Franz-WernerTheobald, KarlheinzGorcyca, KatherineIorga, Serban R.Ansell, David